Livia Pellegrini

Livia Pellegrini

Auto-generated profile, based on publicly available information

Livia Pellegrini

IVI Institute Research Alliance, IVI Fertility, Rome, 00161 Rome, Italy

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2021 in Fertility and Sterility
Verified
Journal Article
Closed access
ABAnna Buigues
Anna Buigues
PDPatricia Diaz-Gimeno
Patricia Diaz-Gimeno
PSPatricia Sebastian-Leon
Patricia Sebastian-Leon
LPLivia Pellegrini
Livia Pellegrini
NPNuria Pellicer
Nuria Pellicer
SHSonia Herraiz
Sonia Herraiz

22 October 2026 in Reproductive Medicine
Verified
Journal Article
Open access
PDF file
BCBeatrice Crestani
Beatrice Crestani
LPLivia Pellegrini
Livia Pellegrini
CTClaudia Tosti
Claudia Tosti
ASAntonella Clara Starace
Antonella Clara Starace
FCFrancesca Ciociola
Francesca Ciociola
MCMauro Cozzolino
Mauro Cozzolino
Intraovarian platelet-rich plasma (PRP) has been proposed as an experimental treatment for women with diminished ovarian reserve and poor ovarian response, but the optimal route of administration remains unclear. This study compared laparoscopic and transvaginal ultrasound-guided PRP administration and investigated whether the route of injection was independently associated with ovarian response and reproductive outcomes. This retrospective multicenter study included 119 women undergoing intraovarian PRP at two Italian fertility centers: 50 received laparoscopic PRP and 69 underwent transvaginal ultrasound-guided administration. In both groups, 3 mL of PRP was injected into each ovary. Post-treatment ovarian response was available for 79 women. Primary outcomes were the numbers of retrieved and mature (MII) oocytes. Secondary outcomes included embryo yield, pregnancy outcomes, and longitudinal changes in ovarian reserve markers. Multivariable linear regression was used to adjust for baseline anti-Müllerian hormone (AMH), antral follicle count (AFC), and double ovarian stimulation (DUO-STIM). Retrieved oocytes were 4.64 ± 3.61 after laparoscopic versus 3.45 ± 3.86 after transvaginal administration (p = 0.06), while MII oocytes were 3.38 ± 2.84 versus 2.83 ± 3.04 (p = 0.25). After adjustment for AMH, AFC, and DUO-STIM, the route of administration was not independently associated with retrieved (β −0.78; 95% CI −2.49 to 0.92; p = 0.37) or mature oocytes (β −0.23; 95% CI −1.56 to 1.11; p = 0.74). DUO-STIM was positively associated with both outcomes. In the transvaginal cohort, a modest early increase in AMH was not sustained over subsequent follow-up. Pregnancy analyses were exploratory because of the limited number of embryo transfers. The route of intraovarian PRP administration was not independently associated with ovarian response after accounting for baseline ovarian reserve and stimulation strategy. These findings do not demonstrate an advantage of laparoscopic administration and support further prospective evaluation of the less invasive transvaginal approach using standardized PRP and stimulation protocols.

14 October 2026 in Journal of Assisted Reproduction and Genetics
Verified
Journal Article
Closed access
PDF file
LMLucia Maresca
Lucia Maresca
LPLivia Pellegrini
Livia Pellegrini
CZCecilia Zanini
Cecilia Zanini
LLLuisa Loiudice
Luisa Loiudice
APAntonio Pellicer
Antonio Pellicer
MCMauro Cozzolino
Mauro Cozzolino

31 July 2026 in Reproductive Biology
Verified
Journal Article
Closed access
LPLivia Pellegrini
Livia Pellegrini
GPGiovanni Pizzi
Giovanni Pizzi
LMLaura Mossetti
Laura Mossetti
VSVincenzo Sorrentino
Vincenzo Sorrentino
MMMagda Messina
Magda Messina
MCMauro Cozzolino
Mauro Cozzolino

15 June 2023 in Archives of Gynecology and Obstetrics
Verified
Journal Article
Closed access
PDF file
LPLivia Pellegrini
Livia Pellegrini
FAFranco De Angelis
Franco De Angelis
STSilvio Tartaglia
Silvio Tartaglia
MTMarco Toschi
Marco Toschi
DGDaniela Galliano
Daniela Galliano
MCMauro Cozzolino
Mauro Cozzolino